Thus, understanding the mechanisms that control progenitor exhausted CD8+ T cell generation, maintenance, and differentiation to a terminal exhaustion state is of particular importance for predicting tumor response to anti-PD-1 treatment and for enhancing the treatment efficacy. This evidence concerns the gene CD8A and neoplasm.